Advanced Medical Solutions Grp PLC
30 April 2007
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of Advanced Medical Solutions Group Plc
existing shares to which voting rights are attached
2. Reason for the notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights x
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify): Initial notification of shareholding under Transparency
Directive
3. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and its
notification obligation: group of companies
4. Full name of shareholder(s) (if different
from 3.):
5. Date of the transaction (and date on which 29 April 2007
the threshold is crossed or reached if
different):
6. Date on which issuer notified: 30 April 2007
7. Threshold(s) that is/are crossed or reached: 12%
8. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction(i)
shares the Triggering
transaction
if possible Number of Number of Number of Number of voting rights % of voting rights
using the ISIN Shares Voting shares
CODE Rights Direct Indirect Direct Indirect
GB0004536594 16,937,661 16,937,661 215,161 215,161 16,922,500 0.15 11.85
B: Financial Instruments
Resulting situation after the triggering transactio
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of
instrument Period/ Date that may be acquired if voting
the instrument is rights
exercised/ converted.
-
Total (A+B)
Number of voting rights % of voting rights
17,137,661 12.00%
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively
held, if applicable:
Name of Company / Fund Number of Shares % of issued share capital
Sun Life Pensions Management Ltd 15,161 0.01062%
Direct
Sun Life Pensions Management Ltd 200,000 0.14009%
Direct
AXA Framlington Framlington Innovative Growth 10,000,000 7.00450%
Indirect
AXA Framlington Biotech 2,550,000 1.78615%
Indirect
Framlington onshore private clients 2,172,500 1.52173%
Indirect
AWF Framlington Health 2,200,000 1.54099%
Indirect
Total Direct 215,161 0.15071%
Total Indirect 16,922,500 11.85336%
TOTAL 17,137,661 12.00407%
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting
rights:
13. Additional information:
14. Contact name: Mary Tavener
15. Contact telephone number: +44 (0)1606 545509
--------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.